RT Journal Article
SR Electronic
T1 The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.01.20242347
DO 10.1101/2020.12.01.20242347
A1 Jiannan Yang
A1 Qingpeng Zhang
A1 Zhidong Cao
A1 Jianxi Gao
A1 Dirk Pfeiffer
A1 Lu Zhong
A1 Daniel Dajun Zeng
YR 2020
UL http://medrxiv.org/content/early/2020/12/03/2020.12.01.20242347.abstract
AB The emergence of coronavirus disease 2019 (COVID-19) has infected more than 37 million people worldwide. The control responses varied across countries with different outcomes in terms of epidemic size and social disruption. In this study, we presented an age-specific susceptible-exposed-infected-recovery-death model that considers the unique characteristics of COVID-19 to examine the effectiveness of various non-pharmaceutical interventions (NPIs) in New York City (NYC). Numerical experiments from our model show that the control policies implemented in NYC reduced the number of infections by 72% (IQR 53-95), and the number of deceased cases by 76% (IQR 58-96) by the end of 2020, respectively. Among all the NPIs, social distancing for the entire population and the protection for the elderly in the public facilities is the most effective control measure in reducing severe infections and deceased cases. School closure policy may not work as effectively as one might expect in terms of reducing the number of deceased cases. Our simulation results provide novel insights into the city-specific implementation of NPIs with minimal social disruption considering the locations and population characteristics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by grants from the National Natural Science Foundation of China (72042018).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe source codes have been made available on Github: https://github.com/JasonJYang/Age-specific-SEIRD. https://github.com/JasonJYang/Age-specific-SEIRD